Recombinant Immunotoxins with Low Endotoxins for Clinical and Animal Studies
关键词: recombinant immunotoxins low endotoxins来源: 互联网
Recombinant immunotoxin (RIT) contains the Fv portion of the antibody fused to the truncated form of toxin and are ongoing in clinical trials for cancer therapy. To obtain high yields of products, RITs are produced in Escherichia coli (E. coli ). As the endotoxin came from E. coli cells and is harmful to animals, it is important to produce the RITs with low endotoxin. This section describes the protocols to produce RITs containing low level of endotoxins.
推荐方法
- 流式细胞仪血小板分析
- 人凋亡相关因子配体(sFas-L)ELISA试剂盒 说明书
- 抗原多态性
- Tracking Antigen-Specific CD8+ T Cells Using MHC Class I Multimers
- Techniques For Studying Murine Natural Killer Cells in Defense Against Viral Infection
- Paul Ehrlichs ;Mastzellen From Aniline Dyes to DNA Chip Arrays: A Historical Review of Developments in Mast Cell Research
- Monitoring Dendritic Cell Activation and Maturation
- HIV-1 Rev Function and RNA Nuclear-Cytoplasmic Export
- Genetic Engineering of a Recombinant Fusion Protein Possessing an Antitumor Antibody Fragment and a TNF- Moiety
- Evaluation of Recombinant Antibodies on Protein Microarrays Applying the Multiple Spotting Technique